Teva-Handok names chief executive
April 17, 2013Manufacturing and Production, Research and Development, Sales and Marketing teva-handok
Teva-Handok has announced the appointment of Yoo Suk Hong as the first chief executive of the business venture between Teva …
Lilly Phase III diabetes boost
April 17, 2013Research and Development, Sales and Marketing diabetes, dulaglutide, lilly
Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …
Dragon’s Den entrepreneur expands into healthcare
April 17, 2013Medical Communications, Research and Development, Sales and Marketing Dragon's den, ab prime advantage, james caan
James Caan, one of the panel of entrepreneurs on TV’s Dragons’ Den, is to expand his business into the healthcare …
Zeno Group hires Rachel Vrettos to lead UK healthcare practice
April 17, 2013Medical Communications, Sales and Marketing Red Door, zeno group
PR agency Zeno Group has confirmed the appointment of Rachel Vrettos as director, Healthcare for its UK operations. Vrettos has …
Mobilising for action in consumer healthcare
April 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing A.T. Kearney, healthcare products, marketing
A new market of consumer-focused healthcare products is emerging to occupy the space between consumer goods and pharmaceuticals – and …
OHE: drugs spend to rise
April 16, 2013Medical Communications, Sales and Marketing ABPI, OHE
UK medicines expenditure is set to grow between 3.1% and 4.1% by 2015, according to a study which the researchers …
New president and chief executive for Aeterna Zentaris
April 16, 2013Manufacturing and Production, Research and Development, Sales and Marketing aeterna zentaris
Aeterna Zentaris has announced that David Dodd has been appointed as its president and chief executive, succeeding Juergen Engel. Dodd …
Celgene appoints new Haematology head
April 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, browne
Celgene has announced the appointment of Karen Browne as business unit director of Haematology, Celgene UK and Ireland. Over the …
ANI poised to take over BioSante
April 15, 2013Sales and Marketing ANI, biosante
US firms BioSante Pharmaceuticals and ANI Pharmaceuticals have tweaked the terms of the merger they announced last year, and which …
Big pharma appointments to PhRMA Board
April 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, Celgene, Merck, Pfizer, PhRMA
Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …
Eisai appoints chief clinical officer
April 12, 2013Manufacturing and Production, Research and Development, Sales and Marketing Eisai
Eisai has announced the immediate appointment of Lynn Kramer to the newly created position of chief clinical officer of Eisai …
Cancer drugs boost Roche
April 12, 2013Sales and Marketing Cancer, Q1, Roche
Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …
Change at centre of NHS plan
April 12, 2013Sales and Marketing Mid Staffs, NHS, putting patients first
The shadow of Mid Staffs looms long over NHS England’s new three-year business plan, with a move towards fundamental change …
Roche signs Huntington’s deal
April 10, 2013Research and Development, Sales and Marketing Huntington's, Isis, Roche
Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …
Bristol-Myers Squibb appoints executive as another retires
April 10, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS
Bristol-Myers Squibb has announced the appointment of Francis Cuss as executive VP and chief scientific officer following Elliott Sigal’s intentions …
MedImmune buys AlphaCore
April 9, 2013Research and Development AlphaCore, AstraZeneca, MedImmune
AstraZeneca’s biologics R&D arm MedImmune has bought private US biotech firm AlphaCore Pharma for an undisclosed sum.The acquisition is part …
Pharma pays doctors £40m
April 9, 2013Sales and Marketing ABPI, Bad pharma, ethics
Health professionals received £40 million in payments from pharma companies last year, according to new figures released by the ABPI.This …
New head at European Medicines Agency
April 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA
The European Medicines Agency has appointed Agneta Brandt as the new head of Infrastructure Services. Brandt joins the Agency from …
Ten pharma firms censured
March 28, 2013Medical Communications, Sales and Marketing ABPI, PMCPA
Ten pharma companies have been found guilty by the PMCPA of failing to maintain high standards over their involvement in …
US nod for Tecfidera
March 28, 2013Sales and Marketing Biogen, FDA, tecfidera
The FDA has given Biogen Idec’s oral multiple sclerosis treatment Tecfidera the green light. Earlier this week Tecfidera (dimethyl fumarate) …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
